Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Organogenesis Partners with National Tissue Engineering Center

publication date: Dec 11, 2007

Organogenesis, Inc. of Massachusetts has signed a memorandum of understanding with China's National Tissue Engineering Center (NTEC) of Shanghai that will establish a three-phase collaboration in regenerative medicine. The first phase of the agreement starts immediately. Organogenesis will export its existing technology to the NTEC, including Apligraf®, a marketed product used in venous ulcers on the leg and diabetic foot ulcers that do not heal normally.  More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital